April 9, 2014
Watertown, New York ----- Dr. Kevin Biglan, a published expert and researcher in the field of Parkinson disease, will be speaking on Saturday, April 12th from 9 a.m. – 10 a.m. at Samaritan Summit Village. The event is free and open to the public.
Dr. Biglan is an Associate Professor of Neurology and the Associate Chair for Clinical Research in the Department of Neurology at the University of Rochester School of Medicine and Dentistry in Rochester, New York. He also serves as Director of the National Parkinson Foundation Center of Excellence and Director of the Huntington Disease Society of America Center of Excellence at the University of Rochester.
Since 2007, Dr. Biglan has been actively involved in the development of telemedicine for the provision of care in patients with Parkinson disease. Over the last six years, he has established a telemedicine network centered at the University of Rochester with two spoke sites located at the long-term care facilities at the Presbyterian Home in New Harford and at the Susquehanna Nursing and Rehabilitation Center in Johnson City. He has been at the forefront of establishing the feasibility of telemedicine in Parkinson disease and Huntington disease, the expansion of its use for clinical care, and the validation of clinical trial outcomes assessed via telemedicine.
Telemedicine offers a unique opportunity for senior care in the community and is something that Samaritan’s Vice President of Long-Term Care Services sees as a benefit for Residents in Samaritan’s two nursing homes. “Telemedicine capabilities will make available a level of expertise in these movement disorders that otherwise would not be available without long distance travel,” explains Tony Joseph. “After having worked closely with Dr. Biglan in the past, I’ve seen first-hand how this can benefit our Residents. It is a service we are working diligently to implement here in Watertown.”
Dr. Biglan’s current research interests focus on identifying clinical phenotypes in pre-manifest Huntington’s disease, identifying disease modifying therapies in Huntington’s disease and Parkinson’s disease and enhancing the delivery of care to patients with chronic neurodegenerative disorders.
For more information about Dr. Biglan’s presentation, please call Samaritan Summit Village at 785- 4422.
News Release #14-008